Try our Advanced Search for more refined results
Life Sciences - December, 2022
240 articles
- The Most-Read Legal Industry Law360 Guest Articles Of 2022
- $1.35M Atty Fee Proposed For Calif., Del. Drug Trial Suits
- ITC Says Apple Watch Infringes Patents But Holds Off On Ban
- 11th Circ. Says Fla. Vaccine Requirement Appeal Isn't Moot
- The Top Patent Damages Awards Of 2022
- Insurers Slam Scouts Plan; FTX To Start Clawback Actions
- French Medical Co. Wants €4.2M Award Over Failed Expansion
- Syngenta, Corteva Pesticide Antitrust Cases Consolidated
- The Biggest Moves In Cannabis Law And Policy From 2022
- Mich. High Court Won't Fast-Track AG's Eli Lilly Insulin Probe
- Key Developments From State Attorneys General In 2022
- DC Circ. Urged To Overturn Endo-Impax Opioid Deal Win
- 6th Circ. Blocks Ky. Abortion Clinic 'Buffer Zone,' For Now
- Athenahealth Whistleblowers Lose Atty Fee Bids In 1st Circ.
- 2022 Law And Policy Highlights In Digital Health Care
- 6th Circ. Tosses 5 Cases Over COVID-19 Insurance Claims
- Fed. Circ. Won't Revive Genentech Lung Disease Patents
- PwC Pins Blame On Valeant In Securities Fraud Suit
- What 3 Legal Industry Trends From 2022 Mean For Next Year
- UK Litigation Roundup: Here's What You Missed In London
- Chancery Tosses AmerisourceBergen Opioid Suit
- Are Winds Of Change Finally Blowing On Patent Eligibility?
- Amgen Fights HHS' Drug Discount Claims At DC Court
- Drugmaker Dinged For Flouting Del. Court's Counsel Rule
- Yoga Video Co. Gaia Faces Investor Suit Over SEC Probe
- UnitedHealth Faces ERISA Suit Alleging Overcharging Scheme
- The Largest Securities Settlements Announced In 2022
- EPA Sued Over 'Inaction' On Endocrine-Disrupting Pesticides
- Judge Trims Boston Scientific Investor's Stock Suit
- Fed. Circ. Revives Patents In IP Suit Over Opioid Generic
- Accused 'Pill Mill' Doc Asks 3rd Circ. To Toss Guilty Plea
- A Numerical Analysis Of FDA Warning Letters In 2022
- Learning From This Year's Legal Industry Discrimination Suits
- Wash. AG Says Kroger, Others Helped Fuel Opioid Epidemic
- Top Government Contracts Cases Of 2022
- Biggest Developments In Antitrust Conduct Cases In 2022
- The 6 Biggest 1st Circ. Rulings Of 2022
- Biden Names 6 New District Court Picks
- Walmart, CVS, Albertsons To Pay $189M In NM Opioid Deals
- 3M, DuPont And Others Sued Over Fire Foam Water Pollution
- BioTelemetry, CardioNet To Pay $44.8M To Settle FCA Case
- Ill. Judge Won't Upset $363M Sterigenics Emissions Verdict
- WTO Dispute Roundup: New Delays Heading Into 2023
- DLA Piper Sued For Malpractice After Gummy Deal Collapses
- 2nd Circ. Says FCA Claims Against Fresenius Already Public
- J&J Expert Says Talc Claims Process To Move Swiftly
- The Future Of Legal Ops: AI Has Important Role To Play
- 4 Proactive Strategies For 'Rocket Docket' Discovery In SDNY
- Teva, Glenmark Get May 2024 Price-Fixing Criminal Trial
- Plaintiffs Seek OK On $255M Juul MDL Economic Settlement
- Monsanto Wins 11th Circ. Redo Of Ga. Doctor's Roundup Case
- Biotech CEOs Lied About HIV Drug, Feds Say
- How DC Became A Consumer Protection Pioneer
- Revived Calif. Bill Would Decriminalize Psychedelics
- Florida's Medical Marijuana Industry: 2022 In Review
- Philips Says It Didn't Mislead CPAP Cleaner Co.'s Customers
- Jazz Pharma Asks Fed. Circ. To Reverse Orange Book Delisting
- Planned Parenthood Slams 'Deficient' Texas Privilege Claims
- Catching Up With Delaware's Chancery Court
- Express Scripts Says Sanction Bid A Tactic Of A Failed Case
- Bayer Asks Chancery To Toss Merck's Talc Liability Suit
- Novartis And Grifols Say Abbott Can't Tank HIV Test Patent
- 9 Considerations For Landlords Renting To Cannabis Cos.
- 5 Drug Pricing Issues To Watch In 2023
- Psychedelic Biz Pledges No IP Suits Over Natural Mescaline
- Judge OKs $75M Ch. 11 Loan From Clovis Secured Lender
- Juul's Massive E-Cig Marketing Deal Won't Derail Altria Trial
- USTR Seeks More Data As WTO Delays COVID-19 IP Vote
- How EU's New Pharma Incentives May Affect US Cos.
- Real Estate Rumors: Vigilant, ABS Partners, DR Horton
- Opana End-Payors Get Final OK Of $15M Impax Deal
- Janssen Thwarting Docs Order In Kickback Suit, Court Told
- Practical Steps For Companies Facing PFAS Risks
- What Really Doomed Kidney Test Patents In Fed. Circ. Ruling
- Leading Conservative Atty Retires After Decades At Jones Day
- Thompson Hine Adds New Enviro Partner In Atlanta
- Health Hires: Barnes & Thornburg, BillionToOne
- Increasing Law Firm Polarization Will Degrade Rule Of Law
- Cannabis Research Center To Open In Chicago
- TCPA Verdict Remand Is A Boon For Class Action Defendants
- FDA Warns CBD Cos. About COVID Claims
- Judge Breathes 6 Months Of Life Into AstraZeneca Patent
- FDA Extends Inspection Delay Guidelines To Medical Devices
- The Biggest Patent Rulings Of 2022
- 3rd Circ. Won't Revive Health Plans' Suits Over Opioid Drug
- Navigating Uncertainties In Section 340B Drug Pricing
- 3 PTAB Cases Offer Guidance For Drafting Method Claims
- Clovis Oncology Ch. 11 Loan Process Down To The Wire
- Chancery Says AmerisourceBergen Suit Not Time-Barred
- PerkinElmer Says Lab Must Face Claim Over COVID Gear
- Breast Implant Maker Gets Injury Suit Tossed
- Best Practices For Cannabis Cos. Managing A Product Recall
- Coca-Cola Distributor Fired Medical Pot Patient, Suit Alleges
- Alleged Insider Trader Sues For Fees In Del. Bioverativ Suit
- HHS Pans Pfizer's 'Far-Fetched' Kickback Views At High Court
- Texas Justices Say No Remote Jurors In J&J Pelvic Mesh Trial
- Masimo Launches Counterattack In Apple Watch IP Fights
- Fed. Circ. Pauses 'Orange Book' Delisting For Jazz Drug
- Enviro Groups Allege EPA Delayed Ethylene Oxide Air Rules
- Georgia Agencies Sued For Failure To Cover Trans Benefits
- Navigating The Unique Challenges Of An OIG Investigation
- What To Expect From Colo. Therapeutic Psychedelics Law
- Merck's $1.35B Merger With Biotech Faces Investor Suits
- Why States Need Clear Standards For Cannabis Testing Labs
- LabSolutions CEO Guilty In $187M Telemed Billing Scheme
- Two Lenders Vie For $75M Clovis Oncology Ch. 11 DIP Loan
- 8th Circ. Won't Upend $21M Biomet Hip Implant Verdict
- How To Deal With Difficult Clients, Practically And Ethically
- Investment Cos. Say CBD Biz Defrauded Them Of $4.7M
- DeSantis Petitions Fla. Justices For COVID-19 Vax Grand Jury
- Illumina Tells FTC Commissioners Grail Deal Will Save Lives
- 7 Firms Lead Metals, Pharma And Wellness Co. SPAC Deals
- Teva, Apotex Win Ax Of Patents In Sleep Drug Suit
- Medical Device Co. Strikes $14.5M Deal To Settle FCA Claims
- Glove Co. Wants $68M Labor Probe Concealment Suit Ended
- Pesticide Giants Ask To Exterminate FTC's 'Pay-To-Block' Suit
- 2 Firms Drive Up To $6B Deal For Nimbus' Psoriasis Drug Biz
- Ravgen Fetal DNA Testing Patent Survives PTAB Review
- Munger Tolles & Olson Promoting 3 To Partner In 2023
- Ga. Family Sues Over Father's Kratom-Linked Death
- 6th Circ. Rejects Challenge To Opioid MDL Fee Order
- Lab Director Gets 5 Months For Duping FDA Before Outbreak
- Vape Co. Can't Undo FDA Denial Of Flavored E-Cig Fluids
- Juul To Pay Pa. $38.8M To Settle Youth Marketing Claims
- Allergan Snags Win In Investor Class Action Over Implants
- Deliberations Start In $187M Genetic Testing Scheme
- Biz Owner Can't Nix 50 Cent's Suit On Penile Enhancement Ad
- LegitScript Can't Pause Drug Price Check Blacklisting Suit
- Tulane, Insurer Get More Time For COVID Coverage Settlement
- CR Bard, AngioDynamics Spar Over Timing Of Damages Trial
- Biotech Co. Gets Investor Suit Over Failed COVID Test Tossed
- Atty's Real Estate Cos. Want Out Of Ex-NFL Player's PPE Suit
- Biosciences Co. Says 3 Ex-CEOs Pilfered Cardiac Test IP
- Walgreens And CVS Finalize $10.7B Opioid Fallout Deal
- Catching Up With Delaware's Chancery Court
- Fed. Circ. Rulings That Gave Patent Law A New Spin In 2022
- Federal Courts Should Adopt Supreme Court's Amicus Stance
- Top Firms Make Growth A Priority For 2023
- The 2022 Law360 Pulse Leaderboard
- Detroit Says Updated Cannabis Ordinance Is Constitutional
- Clovis Oncology Hits Ch. 11 With $754.5M Debt And Sale Plans
- Amgen To Buy Ireland's Horizon Therapeutics For $28B
- 3rd Circ. Affirms Takeda's Nix Of Prevacid Antitrust Claims
- Medical Device Co. Blames Judge For Sinking Patent Case
- Centene Stockholder Sues In Alleged Medicaid Fraud Scheme
- ITC Delays Final Ruling On Apple Watch Import Ban
- Life Sciences Co. Says Ex-Worker, Rival Swiped Trade Secrets
- Philips Wants Latest CPAP Foam MDL Complaint Tossed
- J&J Unit Hit With $12M Verdict In Spinal Implant IP Suit
- Novavax Brass Sued In Del. For Touting Failed COVID Vaccine
- PTAB Wipes Out Sex-Selection Patent In Pig Breeding IP Row
- Drugmaker's Knowledge Of Suits Bars Coverage, Court Told
- 1st Circ. Revives Puerto Rico Urologists' Antitrust Case
- Texas Abortion Provider Gets Bounty-Hunter Suit Tossed
- Pa. Cannabis Co. Didn't Pay For Plant Growth IP, Firm Says
- Geico Seeks $2.4M From Health Centers For False Claims
- 6th Circ. Takes On Kentucky Abortion Clinic's 'Buffer Zone'
- AbbVie Sales Rep Alleges Age Discrimination In Promotions
- Lab Exec Seeks Probation For FDA Fraud Tied To Outbreak
- Texas AG Says Mallinckrodt Trust Can't Be Used For Atty Pay
- 1st Circ. Doubts Error In Hedge Fund Priest's Fraud Verdict
- Teva's UK Appeal Over Patent For MS Drug Gilenya Falls Flat
- FDA Graphic Cigarette Warnings Go Up In Smoke
- Merck Sheds Nearly 1,200 Shingles Vaccine Suits
- Ex-Florida Pain Doctor Gets 3½ Years For Insys Kickbacks
- Novartis Can't Beat Suit Over Eye Injection Treatment
- Ga. County Says It 'Dropped Ball' Approving Sterigenics Plant
- Ex-Theranos Exec Balwani Gets Nearly 13 Years For Fraud
- Gov't Recommends High Court Review Intent In FCA Cases
- Justices Seem Disinclined Toward Any Major FCA Upheaval
- 5th Circ. Revives Some Medtronic Pacemaker Claims
- EU Also Probing Cochlear's Hearing Implant Merger
- Ga. Co. Agrees To Pause E-Cigarette Sales In Feds' Case
- Science Investing Biz Sells 5% Stake In Biotech Co. For €145M
- Arnold & Porter Punished For Opioid Lapses, Averts Contempt
- Fla. Court Axes Zantac MDL Claims, Citing Lack Of Experts
- Juul Cuts Deal To End MDL On Eve Of Bellwether Trial
- Balwani May Get More Prison Time Than Holmes, Experts Say
- Justices Skeptical About Limits On Gov't FCA Dismissal Right
- 9th Circ. Backs CVS' Win Over $121M Drug Overcharge Claim
- Juul Founders Say NY's Illict Marketing Claims Must Fall
- Judge Shrinks J&J's Potential Damages Recovery In IP Row
- FTC Staff Warn Against Changing Juul-Altria Standard
- Fed. Circ. Wary Of Reviving Gilead's Lexiscan IP Suit
- Dems Press Patent Office On Pharma 'Abuse' Of System
- Gov't Says Gilead Can't Shake HIV Drug Patent Suit
- USTR Calls For More Time On IP Waiver Expansion Decision
- Lipitor Buyers Say Calif. Group Can't Move Claims Out Of NJ
- L'Oreal Case Highlights Legal Risks Of Anti-Aging Claims
- Teva Case Aims Europe's Pharma Crackdown At IP Loophole
- Elizabeth Holmes Asks To Stay Out Of Prison During Appeal
- Brown Rudnick Hires New UK IP Chief From Fieldfisher
- Pfizer, BioNTech Seek To Nix Moderna Vax IP Suit, Countersue
- Actelion Hit With RICO Suit Over Blood Pressure Drugs
- Del. Court Won't Pause 'Orange Book' Delisting
- Drug Co. Must Provide Docs In False Probiotic Claims Case
- Essilor To Pay $23.8M To End Calif. Insurance Fraud Probe
- Facing Potential ITC Ban, Apple Files IP Suit Over Health Tech
- DuPont Says It Didn't Contaminate Fla. City Well Water
- Catching Up With Delaware's Chancery Court
- EU Wants Illumina To Unwind $8B Grail Deal 'Swiftly'
- CSX Must Face Rail Worker's Cancer Suit, Appeals Court Says
- 1st Circ. Skeptical Of Ex-NuVasive Rep's Noncompete Appeal
- Deal For Crypto Biz Circle Among 2 SPAC Mergers Falls Apart
- 3 Pricing Trends In Law Firm Use Of Litigation Funding
- The 2022 Law360 Pulse Prestige Leaders
- In Law Firm Race For Revenue, Top Dogs Stand Alone
- Fed. Circ. Won't Rethink Axed Stanford Kidney Test Patents
- Elizabeth Holmes Appeals Conviction, Sentence To 9th Circ.
- Doctor Repped By RFK Jr. Targets COVID Misinformation Law
- Target, Starbucks Sold Recalled Food With Bacteria, Suit Says
- CVS, Walgreens Take Aim At $650M Opioid Verdict
- CORRECTED: Cannabis REIT Wants Out Of Risky Investment Claims
- EPA Nets Deal With Ohio Steel Plant Over Lead Emissions
- Biden Signs Marijuana Research Bill Into Law
- Compliance Considerations For Virtual Ketamine Clinics
- Interest Rates Doom Lender, Crypto Winter Persists
- Pierre Fabre Accused Of Selling Cancerous Dry Shampoo
- Alcon Gets More J&J Unit Eye Surgery IP Axed At PTAB
- Seasoned Litigator Joins Baker Botts In Dallas From Foley
- Safeguarding Attorneys' Greatest Asset: Our Mental Health
- How 6th Circ. Flint Ruling Adds To 5th Amendment Case Law
- How The Amgen Case May Affect Patent Owners, Prosecutors
- Theranos Exec Balwani Wants Probation As Feds Seek 15 Yrs.
- Top Opioid Target Kroger Inks $85M Deal, With $25M For Attys
- 11th Circ. Backs Ex-Doctor's Conviction In Prescription Case
- Masimo Clarifies Some Proxy Notice Rules Hit In Del. Suit
- IP Forecast: Jury To Hear Apple-Ericsson Licensing Battle
- Biotech Co. Accuses Citadel Securities, Others Of Spoofing
- Nev. Pharma Board Fights To Keep Pot A Schedule I Drug
- NJ Judge Backs Bausch Patents On Psoriasis Drugs
- BCBS Calls New Bid To Remand Pot Coverage Suit 'Baseless'
- Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver
- 10 Things To Know About The Coming EU Unified Patent Court
- Blocking A Second Punitive Damages Award In Product Cases
- Pharma Co. Slams Bid To Delay 'Orange Book' Delisting
- Trans W.Va. Medicaid Participants Urge 4th Circ. To Affirm Win
- Deals Rumor Mill: CoinDesk, News Corp., Liverpool FC
- Lab Exec Gets 1 Year For FDA Fraud Tied To Deadly Outbreak
- Payment Recovery Co. Wants Attys On Hip Implant MDL Team